IGF-1 treatment enhanced circulating levels of angiogenic factors TGF-β and VEGF, while it reduced the enzymes associated with cardiac injury (CK-MB and LDH) in rats with induced myocardial infarction. The gene discussed is IGF1; the disease is myocardial infarction.